Meropenem Labatec i.v. 500 mg, poudre pour injection ou perfusion

7680594630017 CH-59463 poudre pour injection ou perfusion
Meropenem Labatec i.v. 500 mg, poudre pour injection ou perfusion
Meropenem Labatec i.v. 500 mg, poudre pour injection ou perfusion
Meropenem Labatec i.v. 500 mg, poudre pour injection ou perfusion
1 / 3
google

Article details

Package size
10 x 500
Selling units
10
Measure
mg
Galenic form
poudre pour injection ou perfusion
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
05/06/2026
Summary of Product Characteristics
Français
05/06/2026
Summary of Product Characteristics
Italien
05/06/2026

Detailed composition

Substance Quantity Type Category
meropenemum
500.0 MG Substance Wirkstoff (Principe actif)
meropenemum trihydricum
- Substance WIZUS
natrii carbonas
- Substance HNIDK
natrium
45.1 MG Substance HBESI

Reimbursement information

Public price
CHF 137.90
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/08/2010

Authorization holder

Labatec Pharma SA

1217 Meyrin

Authorization information

Swissmedic authorization number
59463
Drug name
Meropenem Labatec i.v., poudre pour injection ou perfusion
Galenic form
PULPA
ATC Code
J01DH02
Authorization status
Z
Dispensing category
A
First authorization
18/12/2009
Authorization expiration date
31/12/9999
IT Number
08.01.25
Domain
Human medicine

Package details

Description (FR)
MEROPENEM Labatec 500 mg i.v. flac 10 pce
Description (DE)
MEROPENEM Labatec 500 mg i.v. Durchstf 10 Stk
Market launch
18/12/2009
Narcotic (BTM)
No

Original drug

Meronem, Pulver zur Herstellung einer Injektions-/Infusionslösung
GTIN: 7680531050250
CHF 158.20
View original

Other package sizes (1)

MEROPENEM Labatec 1 g i.v. flac 10 pce
10 x 1 G
GTIN: 7680594630024
View
Buy us a coffee Explore the data